The study was terminated in the first stage after 14 patients enrolled at 4 institutions.
Design: Survey of 1,387 hemodialysis patients enrolled at baseline in the Hemodialysis (HEMO) Study.
This report includes the first 298 adult patients enrolled at 5 centers of the Consortium.
Of the 401 patients enrolled at 34 centers from across Canada, a cohort of 183 patients did not receive chemotherapy during the 16-week study period.
This was a small study with only 50 patients enrolled at a single center.
Eight (25%) of 32 patients enrolled at the phase II dose experienced a pathologic complete response.
Often overlooked issues include consideration of the geographic region and the number of patients enrolled at each study center.
This retrospective cohort study analyzed patterns of frequent ED use for 4087 patients enrolled at an academically-affiliated primary care clinic.
RESULTS: Of the 3,160 patients enrolled at 72 contributing sites, major in-hospital complications occurred in 0.66%, and postdischarge major events occurred in 4.8% within the first 30 days.
Due to resource constraints, we only assessed metabolic status in the 250 patients enrolled at Mulago.
The number of patients enrolled at PHC facilities, district hospitals and regional hospitals were 19 273 (66%), 2483 (8.5%) and 7447 (25.5%) respectively.
